Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
89 Cards in this Set
- Front
- Back
- 3rd side (hint)
acid fast microorganisms stain what color with the acid fast stain?
|
red
|
|
|
Color of gram positive cells
|
purple
|
|
|
murein/peptidoglycan peptide crosslinks form between what sugars?
|
N-acetylmuramic acid
|
|
|
between what amino acids does transpeptidation occur
|
D-alanine to D-alanine
|
|
|
where do the peptide chains form in gram neg. organisms?
|
diaminopimelic acid and D-alanine
|
|
|
what are the 3 components of LPS
|
Lipid A, Core, and O antigen
|
|
|
What organisms have LPS?
|
gram negative bacteria
|
|
|
What is the probable function of the O antigen?
|
it is hydrophillic ( imparts resistance to hydrophobic compounds such as bile salts and antibiotics)
|
|
|
What transport mechanism uses the proton movie force (symport)
|
active transport
|
|
|
how do gram neg. bacteria allow for entry of small esential hydrophilic molecules
|
porins
|
|
|
what are siderophores?
|
chelating compounds that bind iron
|
|
|
where does oxidative metabolism take place in bacterial cell?
|
the cytoplasmic membraine
|
|
|
MOA of β-lactams
|
Interfere with cell wall cross-linking through interaction with penicillin-binding proteins (transpeptidases); *auto*lysis
|
|
|
list the β-lactams
|
Penicillins, cephalosporins, carbapenems, monobactams
|
|
|
MOA of bactracin
|
inhibits the generation of a membraine lipid carrier required for the transfer of murein monomeric units from the cytoplasm to the growing chain
|
|
|
MOA of Glycopeptides
|
binds to D-ala-D-ala terminal amino acids on disaccharide subunits blocking their addition to the growing chain of disaccharides (murein)
|
|
|
list Glycopeptides
|
vancomycin
|
|
|
MOA of Imidazoles
|
Blocks synthesis of ergosterol required for fungal cell wall integrity
|
|
|
list Imidazoles
|
fluconazole, itraconazole, voriconazole, posaconazole
-conazole |
|
|
MOA of Echinocandins
|
Blocks β-glucan synthesis, a major constituent of fungal cell walls
|
|
|
list echinocandins
|
caspofungin, mycofungin
-fungin |
|
|
MOA of lipopeptides
|
Forms channels in cell membranes of Gram-positive bacteria resulting in K+ leakage and metabolic death
|
|
|
list lipopeptides
|
daptomycin
|
|
|
MOA of polyene
|
Bind to sterols in eukaryotic cell membranes, leading to membrane leakiness and, at high levels, lysis
|
|
|
MOA of Sulfonamids
|
Competitive inhibitor of dihydropteroate synthesis; blocks synthesis of tetrahydrofolate and cell-linked metabolic pathways (folate antagonist)
|
|
|
list sulfonamids
|
sulfamethoxazole, sulfadiazine
sulfa-- |
|
|
MOA of trimethoprim
|
Inhibition of bacterial dihydrofolate reductase
|
|
|
MOA of aminoglycosides
|
Bind to 30S subunit of bacterial ribosome; cause translational misreading and inhibit elongation of protein chain; kill by blocking initiation of protein synthesis
|
|
|
list aminoglycosides
|
gentamicin, tobramycin, streptomycin, amikacin, neomycin
|
Aminoglycosides Tackle Susceptible Gram Negatives
|
|
MOA of macrolides
|
Bind to ribosome 50S subunit; inhibit protein synthesis at chain elongation step
|
|
|
list macrolides
|
erythromycin, azithromycin, clarithromycin
--thromycin |
|
|
MOA of chloramphenecol
|
same as macrolides (binds to 50s subunit)
|
|
|
MOA of Rifampin
|
Binds to bacterial RNA polymerase and blocks transcription (synthesis of RNA) at initiation step
|
|
|
MOA of Metronidazole and nitrofurans
|
anearobic bacteria and protozoa partially reduce to unstable nitro groups which are incorporated into DNA and lead to strand breakage
|
|
|
MOA of fluoroquinolones
|
Interfere with DNA replication by inhibiting the action of DNA gyrase and/or topoisomerase IV
|
|
|
list fluoroquinolones
|
ciprofloxacin, levofloxacin, gatifloxacin, moxifloxacin, gemifloxacin
-floxacin |
|
|
MOA of linezolid
|
blocks the formation of the initiation complex---inhibits protein synthesis (usually at 50s)
|
|
|
MOA of tetracycline
|
inhibits tRNA binding to ribosome (30s)
|
|
|
MOA of nalidixic acid
|
inhibits DNA gyrase (topoisomerase II)
|
|
|
protein synthesis inhibitors are generally _____ except aminoglycosides which are ____
|
bacteriostatic, bactericidal
|
|
|
what surface protein can bateria change to avoid immune recognition
|
pillin
|
|
|
purpose of DNA gyrase
|
supercoiling of bacterial DNA
|
|
|
purpose of topoisomerase I
|
relaxes supercoils by making single-strand breaks in the DNA
|
|
|
what is phase variation
|
change in flagellar proteins
|
|
|
what is the electron aceptor and product of lactic acid fermentation
|
pyruvate-> lactate
|
|
|
what is the electron aceptor and product of ethanol fermentation
|
acetyl CoA-> ethanol
|
|
|
how does attenuation work?
|
Atenuation sequences occur on DNA with segments A, B, C, and D if the ribosome stalls allowing a stem-loop structure to form between B and C then transcription will be able to continue, but if the ribosome continues quickly from A to B allowing a stem-loop structure to form between C and D then the ribosome will be kicked off the DNA and transcription is terminated
|
|
|
what is an induceable enzyme?
|
the transcription of the enzyme is controlled by an operon sequence and a repressor protein
|
|
|
what does an inducer do?
|
causes a confirmational change in the repressor protein causing it to detach from the operon and transcription can continue
|
|
|
aminoglycosides work better on areobes or anaerobes?
|
aerobes because it is not taken up under anaerobic conditions
|
|
|
nitrofurantoin is only useful in what type of infection
|
urinary tract
|
|
|
mechanism of resistance to b-lactams
|
Hydrolysis of β-lactam ring by β-lactamase
|
|
|
mechanism of resistance to methicillin and penicillins
|
Change in penicillin-binding protein (transpeptidase); not on a plasmid
|
|
|
mechanism of resistance to tetracycline
|
Efflux pump pushes drug out of cell
|
|
|
mechanism of resistance to aminoglycosides
|
Enzymatic modification of DRUG by plasmid encoded enzyme; drug has reduced affinity for ribosome, and transport into cell is reduced
|
|
|
mechanism of resistance to sulfonamides
|
Sulfanilamide-resistant dihydropteroate synthase
|
|
|
mechanism of resistance to trimethoprim
|
Trimethoprim-resistant dihydrofolate reductase
|
|
|
mechanism of resistance to erythromycin /macrolides
|
Enzymatic modification (methylation by methylase) of 23S ribosomal RNA
|
|
|
mechanism of resistance to chloramphenicol
|
Acetylation of hydroxyl groups of chloramphenicol transacetylase; interference with transport into cell
|
|
|
mechanism of resistance to oxazolidinones
|
Point mutations in 23S ribosomal RNA; not on a plasmid
|
|
|
mechanism of resistance to quinolones (fluoroquinolones and naladixic acid)
|
Mutations in genes encoding DNA gyrase and topoisomerase IV and/or eflux pumps; not on a plasmid
|
|
|
mechanism of resistance to vancomycin
|
change in binding site (from D-ala-D-ala terminal amino acids to D-ala-D-lactate
|
|
|
mechanism of tolerance to b-lactams
|
lack of autolysin
|
|
|
gram neg. adhesions and their ligand
|
pili(fimbriae) to glycolpids, surface protein (invasin) to integrins, capsules
|
|
|
gram + adhesions and their ligands
|
surface protein to fibronectin, capsules
|
|
|
list 6 ways that bacteria avoid complement activation
|
1.Coat with capsule (e.g., staphylococci) 2.Coat with IgA antibodies 3.Coat with Sialic acid on LPS 4.Apply appropriate inhibitor of activation to surface: bind factor H ; bind decay-accelerating factors ; mimic component C4bp
5.Cover up target of membrane attack complex (e.g., E. coli, salmonellae) 6.Inactivate complement chemotaxin C5a; activate surface of plasminogen to plasmin which cleaves C3b |
|
|
how do bacteria inhibit phagocyte recruitment and function?
|
increase cAMP preventing mobilization or produce C5a peptidase which inactivates the chematactic product of the complement cascade
|
|
|
how do some bacteria kill neutrophils and macrophages?
|
leukocidin exotoxins
|
|
|
how does protein A reduce opsinization?
|
binds IgG at the Fc portion so that phagocytic cells can't use the antibodies to get a grip
|
|
|
name 4 ways in which bacteria survive phagocytosis
|
1. inhibition of phagosome fusion with lysosome 2. escape into the cytoplasm (e.g. listeriolysin forms pores in the phagosome) 4.inherant resistance to lysosomal enzymes 5.inhibit lysosomal oxidative killing (e.g catalase breaks down H2O2)
|
|
|
how do superantigens work?
|
bind to Vb domain on TCR which makes the TCR more likely to bind to the MHC despite a lack of TCR-MHC antigen compatability
|
|
|
how do trypanosomes evade antigen recognition in sleeping sickness?
|
Trypanosomes are covered with a thick protein coat called variable surface glycoprotein, which undergoes periodic antigenic changes during the infection
|
|
|
what causes relapsing feaver?
|
borreliae undergo antigenic variation of their major surface antigen
|
|
|
what is the difference between antigenic shift and antigenic drift
|
minor changes in virus antigens which occur every 2-3 years is drift; majoir antigenic changes which take place ~10yrs is antigenic shift
|
|
|
what viral proteins change in antigenic variation
|
hemeagglutinin and neuraminidase
|
|
|
what is the function of staphlokinase?
|
it cleaves host plasminogen into plasmin which then degrades both IgG and the complement protein C3b
|
|
|
what are the A-B toxins?
|
shiga, diptheria, cholera, and tetanus
|
|
|
what does diptheria toxin do?
|
ADP ribosylates elongation factor 2
|
|
|
describe the MOA of heat-labile enterotoxin of Escherichia coli, and pertussis toxin ?
|
ADP ribosylates a G protein that stimulates adnylate cyclase, increading CAMP
|
|
|
what toxins cleave intracellular proteins responsible for the fusion of intracellular vesicles with the plasma membrane?
|
Botulinum and tetanus toxins
|
|
|
what type of toxins modulate actin?
|
type III cytotoxins
|
|
|
what are the pattern recognition receptors?
|
endotoxin from Gram-negative bacteria, lipoteichoic acid from Gram-positive bacteria, lipoglycans from the mycobacteria, and mannans from yeast
|
|
|
by what pathway does exotoxin activate complement?
|
alternative pathway
|
|
|
What is the Waterhouse-Friderich syndrome?
|
adreanal insufficiency resulting from DIC
|
|
|
how does endotoxicity result in DIC?
|
Endotoxin contributes to coagulation of blood in three ways: clotting factor XII (the so-called Hageman factor) is activated to set off the intrinsic clotting cascade; platelets release the contents of their granules, which are involved in clotting; and neutrophils release proteins known to stabilize fibrin clots.
|
|
|
what is the order of release of sepsis mediators?
|
C5a, then tumor necrosis factor α (TNF-α) triggers the release of interleukin 1 (IL-1) and IL-6 (IL-6 does not cause shock)
|
|
|
name some membrane damaging toxins and their MOA
|
lipase (eg. Lecithinase), hemolysins
|
|
|
what type of toxin is Staph aureus's a-toxin?
|
a homoggenous pore former
|
|
|
what type of toxin is streptolysin O?
|
heterogenous pore former
|
|